• 1
    Farmer DG, Amersi F, Kupiec-Weglinski JW, Busuttil RW. Current status of ischemia and reperfusion injury in the liver. Transplant Rev 2000; 14:106126.
  • 2
    Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific early and late chronic events after organ transplantation. Transplant Rev 1996; 10:108127.
  • 3
    Liu DL, Jeppsson B, Hakansson CH, Odselius R. Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg 1996; 131:442447.
  • 4
    Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF. CD4+ T-lymphocytes mediate ischemia/reperfusion–induced inflammatory responses in mouse liver. J Clin Invest 1997; 100:279289.
  • 5
    Le Moine O, Louis H, Demols A, Desalle F, Demoor F, Quertinmont E, Goldman M, et al. Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology 2000; 31:12661274.
  • 6
    Horie Y, Wolf R, Chervenak RP, Jennings SR, Granger DN. T-lymphocytes contribute to hepatic leukostasis and hypoxic stress induced by gut ischemia/reperfusion. Microcirculation 1999; 6:267280.
  • 7
    Burne MJ, Daniels F, Ghamdour AE, Mauiyyedi S, Colvin RB, O'Donnell MP, Rabb H. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108:12831290.
  • 8
    Rabb H, Daniels F, O'Donnell M, Haq M, Saba SR, Keane W, Tang WW. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Phys 2000; 279:F525F531.
  • 9
    Amersi F, Farmer DG, Shaw GD, Kato H, Coito AJ, Kaldas F, Zhao D, et al. P-selectin glycoprotein ligand-1 (rPSGL-Ig) mediated blockade of CD62 selectin molecules protects steatotic liver grafts from ischemia/reperfusion injury. Am J Transplant 2002; 2:600608.
  • 10
    Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104:16311639.
  • 11
    Kato A, Yoshidome H, Edwards MJ, Lentsch AB. Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6. Inflamm Res 2000; 49:275279.
  • 12
    Yoshidome H, Kato A, Miyazaki M, Edwards MJ, Lentsch AB. IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. Am J Pathol 1999; 155:10591064.
  • 13
    Takeda K, Akira S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev 2000; 11:199207.
  • 14
    Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996; 4:313319.
  • 15
    Thierfelder WE, Van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996; 382:171174.
  • 16
    Shen XD, Ke B, Zhai Y, Amersi F, Gao F, Melinek J, Anselmo D, et al. CD154-CD40 T cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury and its blockade facilitates and depends on heme-oxygenase-1 mediated cytoprotection. Transplantation 2002; 74:315319.
  • 17
    Sato K, Balla J, Otterbein L, Smith NR, Brouard S, Lin Y, Czismadia E, et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse to rat cardiac transplants. J Immunol 2001; 166:41854194.
  • 18
    Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemia myocardium. J Pharm Meth 1985; 4:157167.
  • 19
    Suzuki S, Toledo-Pereyra LH, Rodrigyez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and Cyclosporine. Transplantation 1993; 55:12651272.
  • 20
    Coito AJ, Kato H, Onodera K, Busuttil RW, Kupiec-Weglinski JW. Fibronectin–α4β1 integrin interactions regulate Th1 cytokine network in tolerant cardiac allograft recipients. Am J Pathol 2000; 157:12071218.
  • 21
    Ke B, Ritter T, Kato H, Zhai Y, Li J, Lehmann M, Busuttil RW, et al. Regulatory cells potentiate the efficacy of IL-4 gene therapy by upregulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol 2000; 164:57395745.
  • 22
    Kato A, Graul-Layman A, Edwards MJ, Lentsch AB. Promotion of hepatic ischemia/reperfusion injury by IL-12 is independent of STAT4. Transplantation 2002; 73:11421145.
  • 23
    Kouretas PC, Kim YD, Cahill PA, Myers AK, To LN, Wang YN, Sitzmann JV, et al. Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog. Circulation 1999; 99:10621068.
  • 24
    Matsumoto T, Yamaguchi M, Kikuchi H, Nakano H, Midorikawa T, Kumada K, Takeda M. Heparin reduces serum levels of endothelin-1 and hepatic ischemia reperfusion injury in rabbits. Surg Today 2000; 30:523525.
  • 25
    Dulkanchainun TS, Goss JA, Imagawa DK, Shaw GD, Anselmo DM, Kaldas F, Wang T, et al. The reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg 1998; 227:832840.
  • 26
    Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, De Broe ME. Identification and kinetics of leukocytes after severe ischemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15:15621574.
  • 27
    Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest 2001; 108:739747.
  • 28
    Lentsch AB, Kato A, Davis B, Wang W, Chao C, Edwards MJ. STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia. J Clin Invest 2001; 108:14751482.
  • 29
    Kishimoto K, Dong VM, Issazadeh S, Fedoseyeva EV, Waaga AM, Yamada A, Sho M, et al. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 2000; 106:6372.
  • 30
    Kato A, Yoshidome H, Edwards MJ, Lentsch AB. Regulation of liver inflammatory injury by signal transducer and activator of transcription-6. Am J Pathol 2000; 157:297302.
  • 31
    Maines MD. The heme oxygenase system: a regulator of second messenger gases. Ann Rev Pharmacol Toxicol 1997; 37:517554.
  • 32
    Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase 1 system in organ transplantation. Transplantation 2002; 74:905912.
  • 33
    Kato H, Amersi F, Buelow R, Melinek J, Coito AJ, Ke B, Busuttil RW, et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001; 1:1218.
  • 34
    Katori M, Buelow R, Ke B, Ma J, Coito AJ, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via anti-apoptotic pathway. Transplantation 2002; 73:28792.
  • 35
    Blydt-Hansen TD, Katori M, Lassman C, Coito AJ, Iyer S, Buelow R, et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidneys from ischemia/reperfusion injury. J Am Soc Nephrol (in press).
  • 36
    Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8:240246.
  • 37
    Brouard S, Otterbein L, Anrather J, Tobiasch E, Bach FH, Choi AMK, Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis via the p38 mitogen activated protein kinase pathway. J Exp Med 2000; 192:10151025.
  • 38
    Amersi F, Shen XD, Anselmo, D, Melinek J, Iyer S, Southard DJ, Katori M, et al. Ex-vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 2002; 35:815823.